ANTIPHONICS IVS: Financial statements 2020
CVR: 35651543
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ANTIPHONICS IVS (CVR 35651543) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. That is an increase of 4.6% compared with the year before. The profit margin was -67.8%. Equity in the 2020 report amounted to DKK 122,533. The solvency ratio was 99.2%.
- Revenue
- DKK 11,726
- Gross Profit
- DKK -6,794
- Profit/Loss
- DKK -7,946
- Equity
- DKK 122,533
- Total Assets
- DKK 123,570
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 12 t. | -7 t. | -8 t. | 123 t. | - |
| 2019 | 11 t. | -6 t. | -7 t. | 4 t. | - |
| 2018 | 70 t. | 45 t. | 36 t. | 13 t. | - |
| 2017 | 41 t. | 14 t. | 9 t. | 24 t. | - |
| 2016 | 45 t. | 21 t. | 16 t. | 40 t. | - |
Official annual report
How creditworthy is ANTIPHONICS IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ANTIPHONICS IVS has published its annual report for 2019. Revenue came to DKK 11,206, and the net result was DKK -6,694.
About ANTIPHONICS IVS
ANTIPHONICS IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2014. The company has been dissolved on 2 December 2021. The company was registered under the industry Indspilning af lydoptagelser og udgivelse af musik. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. Equity in the 2020 report amounted to DKK 122,533.